Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 × Mifepristone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Leiomyoma 5 Triple Negative Breast Neoplasms 3 Prostatic Neoplasms 2 Breast Neoplasms, Male 2 Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 1 Neoplasms 1 Gulf War Illness 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Intraductal, Noninfiltrating 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Cancer Female 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01898312 2022-01-19

BRCA1/2 and Effect of Mifepristone on the Breast

Karolinska Institutet

Phase 2 Completed

Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡